FBN1 and Marfan syndrome: Our study not only adds a new intronic pathogenic variant to the mutational spectrum of the FBN1 gene in MFS but also highlights the importance of including exon/intron boundaries for clinical genetic reporting and the need to conduct functional analyses to verify the pathogenicity of intronic mutations as previously described (Wu et al., 2021).